EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

E for L Aim Public Company Limited (EFORL) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of E for L Aim Public Company Limited THB 0.21, price THB 0.12, upside +75.0%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · TH · ISIN TH1001A10Z00

EF Thin data Sep 24, 2026

E for L Aim Public Company Limited

EFORL · BK

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value 0.2100 THB · Strongly undervalued (+75%)
!Quality 60/100
!Weak Growth (revenue 5y −4.8 %/yr)
!Thin margins · 4.0% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (9/13)
!Narrow moat 35/100
!Insider activity 45/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

2.80 THB 0.0800 THB Fair Value 0.2100 THB Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 0.0800 THB – 2.80 THB · fair‑value band 0.1500 THB – 0.2800 THB · the 0.1200 THB price screens below the 0.2100 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow E for L Aim Public Company in your weekly email

Every Wednesday you see whether E for L Aim Public Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia.

Show more

E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, as well as ICU, transport, and MRI ventilators, anesthesia delivery system, incubator and radiant warmer, phototherapy, spirometer, pulmonary function lab, and cardiopulmonary exercise testing devices. It also provides handheld and ultrasound scanners, high flow oxygen therapy, ceiling pendant, hemodialysis machine, continuous renal replacement therapy, ozone hybrid, patients and medical devices tracking system, MRI infusion and monitor systems, MRI ferrous metal detector, video laryngoscope, hydrogen peroxide plasma sterilizing, and picture archiving and communication devices, as well as clean rooms, anesthesia record system, ECG viewer system, CIS for hemodialysis, telemedicine, telehealth, and PM and after-sale services. In addition, the company offers diagnosis and laboratory products, such as clinical chemistry, hematology, and immunoassay systems, blood gas and banking, urinalysis, hemoglobin A1C analyzer, automated immunoassay analyzer, rapid test kit, coagulation, POCT clinical chemistry analyzers, air purifier, and laboratory information system. Further, it distributes microscopes for life sciences comprising educational microscopes, clinical and laboratory microscopes, and microscopes for biological scientific research. The company was formerly known as Absolute Impact Public Company Limited and changed its name to E for L Aim Public Company Limited in September 2013. E for L Aim Public Company Limited was incorporated in 2005 and is based in Bangkok, Thailand.

Stock analysis

E for L Aim Public Company Limited (EFORL) currently trades at 0.1200 THB, while our model-based Fair Value estimate is 0.2100 THB, implying the stock looks roughly 42.9% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 0.4000 THB per share, and 21 of the 24 models we run sit above the 0.1200 THB price.

Bear case: the Asset-Based group reads lowest at 0.1000 THB, and 3 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.1500 THB (bear) to 0.2800 THB (bull), the price of 0.1200 THB sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

E for L Aim Public Company Limited reported revenue of 1.3B THB in FY2025 versus 2.2B THB in FY2021, a compound −11.9%/yr. Reported net income was 44.6M THB in FY2025, compounding −51.6%/yr from FY2021.

Key figures

Market cap 520M THB (≈ $15.5M) · P/E ratio 12.0 · P/S ratio 0.41 · EPS (TTM) 0.0100 THB · Net margin 3.4% · Return on equity 8.9% · Return on assets (EBIT) 6.8% · Operating margin 1.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).

What moves the price

The share trades about 37% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at 75%, EFORL screens cheaper than that median.

Fair Value models

Bear 0.1500 THB Fair Value 0.2100 THB Bull 0.2800 THB
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0073 THB per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 0.3500 THB 0.6300 THB 1.10 THB 77
Growth DCF 0.3400 THB 0.6000 THB 1.01 THB 76
Owner Earnings 0.2900 THB 0.5300 THB 0.9300 THB 74
All 24 models by family
DCF Models
FCF DCF 0.3500 THB 0.6300 THB 1.10 THB 77
Owner Earnings 0.2900 THB 0.5300 THB 0.9300 THB 74
5Y Revenue Exit 0.1900 THB 0.3000 THB 0.4500 THB 72
5Y EBITDA Exit 0.2800 THB 0.4900 THB 0.7400 THB 74
5Y P/E Exit 0.2100 THB 0.3500 THB 0.5100 THB 70
10Y Revenue Exit 0.2300 THB 0.3600 THB 0.5400 THB 66
10Y EBITDA Exit 0.3000 THB 0.4900 THB 0.7800 THB 67
10Y P/E Exit 0.2600 THB 0.4000 THB 0.5900 THB 63
Earnings-Based
Graham-Dodd 0.0800 THB 0.3500 THB 0.4800 THB 64
Lynch FV 0.0900 THB 0.1300 THB 0.1700 THB 61
PEG = 1.0 0.0900 THB 0.1300 THB 0.1700 THB 57
EPV 0.0900 THB 0.1100 THB 0.1300 THB 74
Multiples
P/E Multiple 0.1800 THB 0.2500 THB 0.3100 THB 63
P/S Multiple 0.1400 THB 0.1900 THB 0.2400 THB 58
P/B Multiple 0.1400 THB 0.1900 THB 0.2400 THB 55
EV/EBIT 0.1600 THB 0.2200 THB 0.2900 THB 65
EV/EBITDA 0.2600 THB 0.3600 THB 0.4600 THB 67
EV/Revenue 0.1100 THB 0.1600 THB 0.2200 THB 53
Asset-Based
NCAV (Graham) 0.0700 THB 0.1000 THB 0.1500 THB 53
Growth DCF
Growth DCF 0.3400 THB 0.6000 THB 1.01 THB 76
Rev-Margin DCF 0.1900 THB 0.3000 THB 0.4500 THB 72
Economic Profit
Residual Income 0.1200 THB 0.1300 THB 0.1400 THB 71
ROIC Compounder 0.0900 THB 0.1100 THB 0.1300 THB 72
Growth Earnings
Growth-Adj P/E 0.1500 THB 0.2100 THB 0.2800 THB 67

Open the full fair value analysis →

Notify me when EFORL reaches fair value

Put EFORL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 60/100

Of which business quality 59 · Market factors (momentum, volatility) 26

Profitability 48
Margins and returns on capital today
Quality Growth 56
Are margins and returns improving?
Cashflow 66
Earnings quality: real cash, not paper profit
Fin. Strength 32
Balance sheet, leverage, solvency risk
Investment 92
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 20
Price trend over the last 3–12 months (market factor)
52W Momentum 10
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.8%
Start year 2020 (pandemic). Over 10 years: −11.6% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.4%
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ −20.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−20.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−45% vs −25%, slowing
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−5% → 5%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 11.2%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Rate on operating basis: 2025 sits 126% above its own trend.

Growth Forecast

Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about −5.5% a year for the price.

Watch EFORL, get fair value alerts →

Compare E for L Aim Public Company Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 83 stocks

Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 60 · Top 25%
Fair Value upside +75% · Above median
Profitability
Return on equity (TTM) 9% · Above median
Return on assets 3% · Above median
Net margin (TTM) 4% · Above median
Operating margin (TTM) 1% · Below median
Growth and dividend
Revenue growth −13% · Bottom 25%
Balance sheet
Debt / equity 0.22× · Above median

Valuation Multiplesvs Medical Distribution median · lower = cheaper

P/E (TTM) 12.0× · Cheaper than median
P/B 0.89× · Cheaper than median
P/S (TTM) 0.41× · Pricier than median
P/FCF 0.2× · Cheapest 25%
EV/EBITDA 6.0× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 44
FUTURE (revenue growth)0 · sector 15
PAST (return on equity)36 · sector 27
HEALTH (low debt)89 · sector 96
DIVIDEND (yield)0 · sector 59

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
McKesson Corporation MCK $880.50 $819.31 −7%
Cencora, Inc COR $312.28 $211.07 −32%
Cardinal Health, Inc CAH $221.27 $141.77 −36%
Henry Schein, Inc HSIC $87.43 $76.86 −12%
Shanghai Pharmaceuticals Holding 601607 ¥16.06 ¥42.67 +166%
Sinopharm Group 1099 HK$15.06 HK$58.89 +291%
Galenica AG GALE CHF 83.45 CHF 61.79 −26%
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥19.67 ¥26.64 +35%
Jointown Pharmaceutical Group 600998 ¥4.89 ¥9.84 +101%
China National Medicines Corporation 600511 ¥26.11 ¥58.47 +124%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "E for L Aim Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/EFORL

Frequently asked questions

Is E for L Aim Public Company Limited (EFORL) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 0.2100 THB versus a price of 0.1200 THB, about +75% upside (undervalued).
What is the fair value of EFORL?
Our model-based fair value for E for L Aim Public Company Limited is 0.2100 THB (as of Sep 24, 2026), built from audited fundamentals. The current price: 0.1200 THB.
What is the quality score of EFORL?
E for L Aim Public Company Limited has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for E for L Aim Public Company Limited (EFORL)?
Our model-based price target is the fair value of 0.2100 THB (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 0.1500 THB, optimistic scenario 0.2800 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the E for L Aim Public Company Limited stock forecast for 2026?
Our models put fair value at 0.2100 THB, about +75% upside versus a price of 0.1200 THB (undervalued). Cautious scenario 0.1500 THB, optimistic scenario 0.2800 THB. The calculation is refreshed regularly with new filings.
What is the revenue of E for L Aim Public Company Limited (EFORL)?
E for L Aim Public Company Limited reported trailing-twelve-month revenue of about 1.3B THB (latest available figure, as of Sep 24, 2026).
What growth is priced into E for L Aim Public Company Limited (EFORL)?
For today's price to be fair in a discounted-cash-flow model, E for L Aim Public Company Limited would have to grow free cash flow by -4.4 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -4.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of EFORL use?
Our models discount E for L Aim Public Company Limited at 11.6 %: a base by market capitalisation (nano), country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For E for L Aim Public Company Limited that is -4.4 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has E for L Aim Public Company Limited (EFORL) delivered so far?
Over the past 5 years revenue at E for L Aim Public Company Limited grew -4.8 % a year. The price currently implies -4.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of E for L Aim Public Company Limited (EFORL) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into E for L Aim Public Company Limited (-4.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of E for L Aim Public Company Limited (EFORL)?
The free-cash-flow yield on the price is 20.34 %: that much free cash flow E for L Aim Public Company Limited produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of E for L Aim Public Company Limited (EFORL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For E for L Aim Public Company Limited it is 0.2100 THB per share (as of Sep 24, 2026), against a price of 0.1200 THB. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is E for L Aim Public Company Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, EFORL trades below its calculated fair value: price 0.1200 THB, fair value 0.2100 THB, a gap of about +75% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of EFORL?
No. The price is what the market pays today (0.1200 THB); the fair value is what the company's own numbers justify (0.2100 THB). For E for L Aim Public Company Limited the two are 0.0900 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is E for L Aim Public Company Limited worth?
The market values E for L Aim Public Company Limited at about 520M THB (market capitalisation, as of Sep 24, 2026). Per share that is 0.1200 THB; our models calculate a fair value of 0.2100 THB per share.
What do the bullish and bearish scenarios say about EFORL?
Our models span a range for E for L Aim Public Company Limited: cautious scenario 0.1500 THB, base 0.2100 THB, optimistic 0.2800 THB per share (as of Sep 24, 2026, price 0.1200 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of EFORL?
E for L Aim Public Company Limited trades at a price-to-earnings ratio of 12.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.2100 THB is built from several models across several years. Other multiples: P/B 0.9, P/S 0.4, EV/EBITDA 6.0.
How solid is the balance sheet of E for L Aim Public Company Limited (EFORL)?
Balance-sheet figures for E for L Aim Public Company Limited (as of Sep 24, 2026): return on equity 8.9%, debt of 0.22 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is EFORL from its 52-week high?
E for L Aim Public Company Limited trades at 0.1200 THB, about 37% below its 52-week high of 0.1900 THB and 20% above the low of 0.1000 THB (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 0.2100 THB is for.
Which stocks are comparable to E for L Aim Public Company Limited?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is E for L Aim Public Company Limited stock attractive at the current price?
The data as of Sep 24, 2026: price 0.1200 THB, calculated fair value 0.2100 THB (+75%), Quality Score 60/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of EFORL calculated?
We run E for L Aim Public Company Limited through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.2100 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. E for L Aim Public Company Limited currently trades 75 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of E for L Aim Public Company Limited (EFORL)?
The closing price on Sep 24, 2026 was 0.1200 THB. Our model-based fair value is 0.2100 THB, about +75% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with E for L Aim Public Company Limited right now?
The price is below even our cautious bear case (0.1500 THB). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (0.1500 THB to 0.2800 THB) leaves room in how you read the outcome.
Where does the earnings growth of E for L Aim Public Company Limited (EFORL) come from?
Earnings per share at E for L Aim Public Company Limited grew −30.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share −19.6 %, EBIT margin −10.3 %, tax rate +3.0 %, residual (interest, one-offs) −6.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of E for L Aim Public Company Limited

How large is the market capitalisation of E for L Aim Public Company Limited (EFORL)?
The market capitalisation of E for L Aim Public Company Limited is 520M THB (≈ $15.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of E for L Aim Public Company Limited (EFORL)?
The price-to-sales ratio of E for L Aim Public Company Limited is 0.41 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of E for L Aim Public Company Limited (EFORL)?
Earnings per share at E for L Aim Public Company Limited are 0.0100 THB (price ÷ EPS = P/E 12.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of E for L Aim Public Company Limited (EFORL)?
The net margin of E for L Aim Public Company Limited is 3.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of E for L Aim Public Company Limited (EFORL)?
The return on equity (ROE) of E for L Aim Public Company Limited is 8.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of E for L Aim Public Company Limited (EFORL)?
On an EBIT basis the return on assets of E for L Aim Public Company Limited is 6.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of E for L Aim Public Company Limited (EFORL)?
The operating margin of E for L Aim Public Company Limited is 1.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at E for L Aim Public Company Limited (EFORL)?
Revenue at E for L Aim Public Company Limited is growing −12.6% versus a year earlier (3y avg −4.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at E for L Aim Public Company Limited (EFORL)?
Earnings per share at E for L Aim Public Company Limited are growing −50.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does E for L Aim Public Company Limited (EFORL) carry?
The net debt of E for L Aim Public Company Limited is 277M THB (fiscal year 2025, ≈ 2.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch E for L Aim Public Company Limited in the live analysis

One click puts E for L Aim Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.